Skip to main content
. 2019 Oct 4;116(40):670–676. doi: 10.3238/arztebl.2019.0670

Table 1. Clinical trials on the use of bacteriophages to treat bacterial infections.

Indication Study type Result Reference
Chronic venous leg ulcers Monocentric,
placebo-controlled phase-I study
No evidence of
relevant side effects
Rhoads et al., 2009 (e14)
Chronic otitis due to multidrug-resistant Pseudomonas aeruginosa Monocentric, randomized,
double-blind, placebo-controlled
phase-I/-II study
– No evidence of
relevant side effects
– Significant symptom reduction
in the treatment arm
Wright et al., 2009 (e15)
Burn wounds colonized with
Staphylococcus aureus and
Pseudomonas aeruginosa
Monocentric,
placebo-controlled phase-I study
No evidence of relevant side effects Rose et al., 2014 (e16)
Escherichia coli–associated
diarrhea in childhood
Monocentric,
placebo-controlled phase-II study
– No evidence of
relevant side effects
– No significant symptom reduction
in the treatment arm
Sarker et al., 2016 (e17)
Chronic rhinosinusitis due to
Staphylococcus aureus
Open-label phase-I study – No evidence of
relevant side effects
– Microbial and clinical response
in 22.2 % of treated patients (2/9)
Ooi et al., 2019 (e18)